Daily non-political popular news in brief.

Bare-metal stents are better for some heart patients

05-11-2007 · EurekAlert!

While drug-eluting stents are effective in keeping open diseased heart arteries, they should not be used for patients who need to have noncardiac surgery a short time after an interventional heart procedure. A presentation at the Society for Cardiovascular Angiography and Interventions in Orlando by cardiologists at Jefferson Medical College indicates that for these patients, bare metal stents provide a safer choice.

Keywords: bare-metal, stents, heart, patients, bare, metal, stent, patient

« Previous | Next »

Similar news on "Bare-metal stents are better for some heart patients":

Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death
03-24-2007 · EurekAlert!
Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit compared rates of complications in thousands of patients who received bare-metal stents (BMS) or DES.
Similar news · Read more »
Second generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
Second-generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
SCAI issues clinical alert on drug-eluting stents and late thrombosis
01-11-2007 · EurekAlert!
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with drug-eluting stents. The document follows hearings held by the FDA's Circulatory Systems Device Panel. SCAI's clinical alert focuses on careful patient selection, meticulous stent implantation, and consistent use of medications to prevent the delayed formation of blood clots that can block blood flow to the heart.
Similar news · Read more »
Bioabsorbable stent shows excellent performance
03-24-2007 · EurekAlert!
The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
Similar news · Read more »
Implant device effectively maintains heart function for transplant-listed patients
03-27-2007 · EurekAlert!
Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients. Research presented today at the American College of Cardiology's 56th Annual Scientific Session reviewed new treatments and interventions, including LVAD implantation and diuretic therapies to support left ventricular function in severely compromised cardiovascular patients.
Similar news · Read more »
Patient knowledge of heart risk profile may help improve cholesterol management
11-26-2007 · EurekAlert!
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the Nov. 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Similar news · Read more »
Hospitalized heart failure patients may benefit from oral tolvaptan
03-25-2007 · EurekAlert!
A diagnosis of worsening acute decompensated heart failure (ADHF) is characterized by the development of dyspnea (shortness of breath) associated with the rapid accumulation of fluid in the lungs. Patients who are hospitalized with ADFA need rapid and sustained fluid retention without risking renal dysfunction. Tolvaptan has been shown to achieve rapid and sustained results in this patient population, according to a study presented today at the American College of Cardiology’s 56th Annual Scientific Session.
Similar news · Read more »
Rx for heart failure: Patient-centered care from a pharmacist
05-14-2007 · EurekAlert!
Heart failure patients have fewer emergency room visits and hospital stays and take their medicine more reliably when under the care of a pharmacist trained in patient-centered care.
Similar news · Read more »
Blending In: Dissolvable stents promise to protect arteries
06-09-2007 · Science News Online
A biodegradable magnesium stent props open clogged blood vessels and then dissolves, circumventing the problems linked to permanent metal stents.
Similar news · Read more »